新型机器人辅助平台联合迷你经皮肾镜取石术与输尿管软镜碎石术的初步临床经验
前瞻性首次人体临床试验纳入13例肾结石患者,评估单一泌尿外科医生使用MONARCH平台行机器人辅助迷你经皮肾镜取石术联合输尿管软镜碎石术的技术可行性,主要终点为手术成功完成,术后监测30天不良事件,术后第30天以低剂量2-3 mm层厚CT评估结石清除效率。12/13例成功完成联合手术,无机器人设备相关不良事件,术后第30天体积减少98.7%(范围72.9%-100.0%),3例发生并发症(Clavien-Dindo 1级2例、2级1例)。
要点
- 13例中12例成功完成机器人辅助迷你经皮肾镜取石术联合输尿管软镜碎石术。
- 无机器人设备相关不良事件,3例发生并发症(Clavien-Dindo 1级2例、2级1例)。
- 术后第30天结石体积减少98.7%(范围72.9%-100.0%)。
核心结论
- 初步研究显示该新型机器人辅助迷你经皮肾镜取石术联合输尿管软镜碎石术平台安全、有效且可行。
研究设计与样本
- 前瞻性首次人体临床试验,在加州大学欧文分校泌尿外科纳入13例因肾结石接受机器人辅助经皮肾镜取石术的患者。
- 主要终点为手术成功完成,术后监测30天不良事件,术后第30天以低剂量2-3 mm层厚CT评估结石消融效率。
- 根据残余结石碎片最大长度分为绝对无结石(A级)、残留<2 mm(B级)、残留2.1-4.0 mm(C级)。
主要发现
- 联合机器人迷你经皮肾镜取石术与输尿管软镜碎石术在13例手术中成功完成12例。
- 未发生机器人设备相关不良事件。
- 术前结石负荷以最大线性测量中位数32.8 mm及基于CT的体积中位数1645.9 mm³量化。
- 利用机器人辅助靶向系统,所有病例均经肾乳头中心单次穿刺建立经皮通道。
- 中位手术时间187分钟(范围83-383分钟)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We sought to evaluate the technical feasibility of performing a combined robotically assisted mini-percutaneous nephrolithotomy (PCNL) and flexible ureteroscopy (URS) procedure by a single urologist using the MONARCH Platform, Urology (Johnson & Johnson MedTech, Redwood City, California). MATERIAL AND METHODS: In this prospective, first-in-human clinical trial, 13 patients underwent robotically-assisted PCNL for renal calculi at the University of California-Irvine, Department of Urology. Successful completion of the procedure was assessed as the primary endpoint. Postoperative adverse events were monitored for 30 days following the completion of the procedure. Stone ablation efficiency was evaluated on postoperative day 30 with low-dose 2-3 mm slice CT scans. Patients were classified according to the maximum length of their residual stone fragments as either absolute stone-free (Grade A), < 2 mm remnants (Grade B), or 2.1-4.0 mm remnants (Grade C). RESULTS: The combined robotic mini-PCNL and URS procedure was successfully completed in 12 of 13 procedures. No robotic device-related adverse events occurred. Preoperative stone burden was quantified by both maximum linear measurement (median 32.8 mm) as well as by CT-based volume (median 1645.9 mm3). Using the unique robotically assisted targeting system, percutaneous access was gained directly through the center of the renal papilla in a single pass in all cases. Median operative time was 187 minutes (range: 83-383 minutes). On postoperative day 30, a 98.7% (range: 72.9%-100.0%) volume reduction was achieved, with 5 Grade A (38.5%), 1 Grade B (7.7%), and 2 Grade C (15.4%). Three patients experienced complications (2 grade 1 and one grade 2 Clavien-Dindo). CONCLUSIONS: Our preliminary investigation demonstrates the safety, efficacy, and feasibility of a unique robotic-assisted combined mini-PCNL and URS platform.
引用
- Landman J, Clayman RV, Cumpanas AD, et al. Initial Clinical Experience With a Novel Robotically Assisted Platform for Combined Mini-Percutaneous Nephrolithotomy and Flexible Ureteroscopic Lithotripsy. J Urol. 2024. PMID: 39115125. doi:10.1097/JU.0000000000004079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。